EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation
Name: Republik Österreich
City: Österreich
Country: Österreich
4. Name of shareholder(s): aws Mittelstandsfonds Beteiligungs GmbH & Co KG 5. Date on which the threshold was crossed or reached: 18.10.2019
6. Total positions

______________________________________________________________________________
| | | % of voting | | |
| | % of voting |rights through |Total of both |Total number of|
| |rights attached|financial/other| in % (7.A + | voting rights |
| |to shares (7.A)| instruments | 7.B) | of issuer |
| | |(7.B.1 + 7.B.2)| | |
|_______________|_______________|_______________|______________|_______________|
| Resulting | | | | |
| situation on | | | | |
| the date on | | . | | |
|which threshold| 3.19 % | 0.00 % | 3.19 % | 1 469 772 |
| was crossed / | | | | |
| reached | | | | |
|_______________|_______________|_______________|______________|_______________|
| Position of | | | | |
| previous | | | | |
| notification | 8.47 % | | | |
|(if applicable)| | | | |
|_______________|_______________|_______________|______________|_______________|

Details
7. Notified details of the resulting situation:

______________________________________________________________________________
|A: Voting rights attached to shares |
|______________________________________________________________________________|
| | Number of voting rights | % of voting rights |
| |_______________________________|________________________________|
| | Direct | Indirect | Direct | Indirect |
| ISIN Code |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
| | 2018) | 2018) | 2018) | 2018) |
|_____________|_______________|_______________|_______________|________________|
|ATMARINOMED6 | | 46 816| | 3.19 %|
|_____________|_______________|_______________|_______________|________________|
| SUBTOTAL A | 46 816 | 3.19 % |
|_____________|_______________________________|________________________________|

______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG |
|2018 |
|______________________________________________________________________________|
| | | |Number of voting | |
| | | | rights that may | |
| | | | be | |
| Type of |Expiration Date|Exercise Period|acquired if the | % of voting |
| instrument | | | instrument is | rights |
| | | | exercised | |
|_____________|_______________|_______________|_________________|______________|
|_____________|_______________|_______________|_________________|______________|
| | | SUBTOTAL B.1 | | |
|_____________|_______________|_______________|_________________|______________|

_____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018 |
|_____________________________________________________________________________|
| | | | Physical / | | |
| Type of | Expiration | Exercise | Cash | Number of |% of voting |
|instrument | Date | Period | Settlement |voting rights| rights |
|___________|____________|___________|_____________|_____________|____________|
|___________|____________|___________|_____________|_____________|____________|
| | | |SUBTOTAL B.2 | | |
|___________|____________|___________|_____________|_____________|____________|

8. Information in relation to the person subject to the notification obligation:
Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

______________________________________________________________________________
| | | | |Financial/ | |
| | | Directly |Shares held| other | |
| No. | Name |controlled | directly |instruments| Total of |
| | | by No. | (%) | held | both (%) |
| | | | | directly | |
|__________|__________________|___________|___________|____(%)____|____________|
| |Republik | | | | |
| 1 |Österreich | | | | |
|__________|__________________|___________|___________|___________|____________|
| |Austria | | | | |
| 2 |Wirtschaftsservice| 1 | | | |
| |GmbH | | | | |
|__________|__________________|___________|___________|___________|____________|
| |aws | | | | |
| 3 |Fondsmanagement | 2 | | | |
| |GmbH | | | | |
|__________|__________________|___________|___________|___________|____________|
| |aws | | | | |
| |Mittelstandsfonds | | | | |
| 4 |Beteiligungs GmbH | 3 | 3.19 %| | 3.19 %|
| |& Co KG | | | | |
|__________|__________________|___________|___________|___________|____________|

9. In case of proxy voting
Date of general meeting: –
Voting rights after general meeting: – is equivalent to – voting rights.

10. additional comments:
Correction of the notification originally sent on 16.10.2019 with regard to the date on which the threshold was reached (value date instead of date of transaction – transaction concluded on 16.10.2019, value date/setting date took place on 18.10.2019).

Note of the Issuer: This is a translation of the received shareholder notification in German language. The translation into English is not binding.

end of announcement euro adhoc

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English

Digital press kit: http://www.ots.at/pressemappe/31479/aom

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender